Steve has spent 35 years in the pharmaceutical and medical device fields and has held both scientific and business leadership positions. At Johnson and Johnson, he led the business development function for Ortho Clinical Diagnostics and at Janssen Pharmaceuticals initiated a new business focused on drug therapy and surgical robotics for kidney cancer treatment as well as being the external innovation lead for the World Without Disease Accelerator and Lung Cancer Initiatives. He previously worked at Novartis as Oncology Commercial Pipeline Leader where he had responsibility for the strategic direction of the global personalized medicine scientific and commercial approach for Phase I through III compounds in the oncology pipeline. Currently, At the Wyss Institute at Harvard Medical School, Steve is a member of the Wyss Mentor Hive who specializes in diagnostics, therapeutics, external innovation, partnership and commercial strategy, and business plan development. The Wyss Mentor Hive is a mentoring program that invites investors and business professionals with significant early stage translational experience, clinical and regulatory experts in driving therapeutic and device development, and serial entrepreneurs with a track record of success to work closely with Wyss entrepreneur teams on startup formation and technology commercialization.